Elevation of CD16+CD56+ NK-cells and down-regulation of serum interleukin-21 (IL-21) and IL-1α after splenectomy in relapsed hemophagocytic lymphohistiocytosis of unknown cause

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Hematology

• Publication date

  2017-04-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/10245332.2017.1311443PMID 28413901
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biological effects of IL-21 on different immune cells and its role in autoimmune diseases.

  2016cited by this paper
• The Interleukin-1 Family.

  2016cited by this paper
• Hemophagocytic lymphohistiocytosis caused by dominant-negative mutations in STXBP2 that inhibit SNARE-mediated membrane fusion.

  2015cited by this paper
• Splenectomy as a treatment for adults with relapsed hemophagocytic lymphohistiocytosis of unknown cause

  2015influential reference
• Successful treatment of cytomegalovirus associated hemophagocytic lymphohistiocytosis with the interleukin 1 inhibitor – anakinra

  2015cited by this paper
• Adult haemophagocytic syndrome.

  2014cited by this paper
• Pediatric Lung Transplantation

  2014cited by this paper
• Splenectomy protects experimental rats from cerebral damage after stroke due to anti‐inflammatory effects

  2013influential reference
• Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab

  2013cited by this paper
• Inherited defects causing hemophagocytic lymphohistiocytic syndrome

  2011cited by this paper
• Splenectomy for an adult patient with refractory secondary hemophagocytic lymphohistiocytosis.

  2011cited by this paper
• A Griscelli syndrome type 2 murine model of hemophagocytic lymphohistiocytosis (HLH)

  2008cited by this paper
• Familial and acquired hemophagocytic lymphohistiocytosis.

  2007cited by this paper
• HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis

  2007cited by this paper
• Familial and acquired hemophagocytic lymphohistiocytosis

  2006cited by this paper
• Hemophagocytic lymphohistiocytosis: Diagnosis, pathophysiology, treatment, and future perspectives

  2006cited by this paper
• Interferon- : an overview of signals, mechanisms and functions

  2004cited by this paper
• Interferon-gamma: an overview of signals, mechanisms and functions.

  2004cited by this paper
• An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder.

  2004cited by this paper
• Splenectomy differentially influences immune responses in various tissue compartments of the body.

  2004influential reference
• Splenectomy in haemophagocytic lymphohistiocytosis: report of histopathological changes with CD19+ B‐cell depletion and therapeutic results

  2000cited by this paper
• Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis.

  1997cited by this paper
• Hypercytokinemia in familial hemophagocytic lymphohistiocytosis.

  1991cited by this paper

• Splenectomy does not improve survival in chronic active Epstein-Barr virus disease patients

  2025cites this paper
• Relationship between brain-derived neurotrophic factor and immune function during dietary supplement treatment of elderly with Alzheimer’s dementia

  2020cites this paper
• Immunological consequences following splenectomy in patients with liver cirrhosis.

  2019cites this paper